ReviewMedical oncology (Northwood, London, England)2025

Targeting immune cells in tumor microenvironment in triple negative breast cancer therapy: future perspective to overcome doxorubicin resistance and toxicity.

Dewajani Purnomosari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.